- Home
- About
-
Procedures
-
Breast
- Breast Implant Illness
- En Bloc Capsulectomy
- Breast Augmentation
- Breast Reconstruction
- Breast Reduction
- Breast Revision Surgery
- Ruptured Breast Implants
- Breast Implant Removal
- Capsular Contracture
- Fat Transfer Breast Augmentation
- Breast Augmentation with Lift
- Breast Lift
- Tuberous Breast Correction
- Breast Explant Surgery
- Male Breast Reduction for Gynecomastia
- Reasons for Breast Revision
- Breast Implant Problems
- Body
- Face
- Nose
- Non-Surgical
-
Breast
- Testimonials
- Media
- Resources
-
Contact
Notice of Open Payments Database
Effective January 1, 2023, California physicians must provide patients with written or electronic notice of the federal Open Payments database. Additionally, physicians must post a statement in their offices and on their websites, informing visitors about the Open Payments database.
In compliance with this law, the office of Dr. Kevin Brenner, MD, FACS, would like to provide the following information.
Drug and medical device manufacturers must report their financial interactions with physicians, including:
- Consulting fees
- Travel reimbursements
- Research grants
- Other gifts
Any payments, ownership interests, and other “transfers of value” must be reported to the Centers for Medicare and Medicaid Services (CMS) for publication in the public Open Payments database.
As a patient, you can use the Open Payments database to search payments made by drug and medical device companies to:
- Physicians
- Physician assistants
- Advanced practice nurses
- Teaching hospitals
The Open Payments Search Tool displays data from January 2015 through December 2021. For more information, you can visit the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page or cms.gov/openpayments.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.